FLUMIST QUADRIVALENT

This brand name is authorized in United States. It is also authorized in Canada, Hong Kong SAR China, Israel.

Active ingredients

The drug FLUMIST QUADRIVALENT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII JAA7BS0D8Y - INFLUENZA A VIRUS A/HAWAII/66/2019 (H1N1) LIVE (ATTENUATED) ANTIGEN
 
Read more about Influenza, inactivated, surface antigen
2
UNII ZD4U7FM04M - INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) LIVE (ATTENUATED) ANTIGEN
 
Read more about Influenza, inactivated, surface antigen
3
UNII 91E648A88W - INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUATED) ANTIGEN
 
Read more about Influenza, inactivated, surface antigen
4
UNII J7LDT2B7CD - INFLUENZA B VIRUS B/WASHINGTON/02/2019 LIVE (ATTENUATED) ANTIGEN
 
Read more about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BB03 Influenza, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02426544
HK Department of Health Drug Office 65690
IL מִשְׂרַד הַבְּרִיאוּת 7584
US FDA, National Drug Code 66019-307

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈